SLC6A14 and intrahepatic cholangiocarcinoma: Furthermore, using a substantial cohort of patients with ICC with bulk transcriptomics data, of which 148 displayed vascular invasion out of 255 patients, we observed that both SLC6A14 and CXCL5 exhibited high expression in the vascular invasion group14 (Figure 2D).